Lifebit specialises in fulfilling RWD and multi-omic data needs across R&D use cases. Our Federated Data Network includes 275 million patients from over 50 sources worldwide (both ex-US and US data) and spans all therapeutic areas and modalities, with a particular focus on molecular and multi-omic data. Lifebit supports major data organisations like Optum, 23andMe, Quest Diagnostics, Flatiron Health, Genuity Sciences and government agencies such as the NIH National Library of Medicine, Genomics England, Singapore’s Ministry of Health (TRUST/PRECISE), Israel's National Genome Project Psifas and the Danish National Genome Center among others.
Generating large amounts of biomedical data has become relatively straightforward. The challenge is finding, accessing, standardising and analysing this sensitive data stored across thousands of disconnected locations. Lifebit solves this challenge with unique and patented federated technology that brings analysis and computation to where data resides. This enables researchers to run analyses on multiple, distributed datasets, in-situ, avoiding the risky movement of highly-sensitive data.
At Lifebit, we are on a mission to harness the power of connected data to drive advancements in precision medicine. Advancing life-saving treatments starts with equipping researchers worldwide with the right data, enabling them to advance research, and develop precise therapies, faster.